AR and small cell carcinoma: Lastly, AR–/NE+ tumors (also termed neuroendocrine prostate cancer [NEPC]) lack AR but show robust NE marker expression and exhibit overlapping features with high-grade NE (small-cell) carcinomas arising in other organ sites (20–22, 28, 29).